<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>NS 1231 [5-(4-chlorophenyl)-6,7,8,9-tetrahydro-1H-pyrrolo-[3.2-h]<z:chebi fb="6" ids="16482">naphthalene</z:chebi>-2,3-dione-3-<z:chebi fb="0" ids="25750">oxime</z:chebi>] belongs to a chemical series of compounds, which exhibit neurotrophic-like activities </plain></SENT>
<SENT sid="1" pm="."><plain>In vitro, NS 1231 rescued nerve growth factor (NGF)-differentiated PC12 cells from <z:hpo ids='HP_0011420'>death</z:hpo> induced by withdrawal of trophic factors </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, NS 1231 stimulated NGF-induced neurite outgrowth of undifferentiated PC12 cells </plain></SENT>
<SENT sid="3" pm="."><plain>At the molecular level, NS 1231 enhanced NGF-induced signalling events, such as TrkA phosphorylation at the Shc-binding site Tyr490 as well as ERK activation in PC12 cells </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, NS 1231 reduced <z:chebi fb="0" ids="31882">NMDA</z:chebi>-induced excitotoxicity in organotypic hippocampal slice cultures </plain></SENT>
<SENT sid="5" pm="."><plain>In a gerbil model of transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>, treatment with NS 1231 reduced the delayed loss of neurons in the hippocampal CA1 layer </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, NS 1231 treatment resulted in a 43% reduction in total <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in the mouse middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model </plain></SENT>
<SENT sid="7" pm="."><plain>The present data thus implicate a therapeutic potential of NS 1231 or structural analogues in treatment of <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
</text></document>